| Pharmaceutical active ingredients: |
| Ticlopidine Hydrochloride |
| Available forms, composition and doses of Platigren: |
| N / A |
| Platigren medical category: |
| Human:Anticoagulants, antiplatelets and fibrinolytics (thrombolytics)Platelet aggregation inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B01AC05 - Ticlopidine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Plaket | Ticlopidine Hydrochloride | Biolab Sanus Farmaceutica |
| Plaketar | Ticlopidine Hydrochloride | Biolab Sanus Farmaceutica |
| Plaquetal | Ticlopidine Hydrochloride | Menarini |
| Plaquetil | Ticlopidine Hydrochloride | Rider Laboratorios |
| Platidine | Ticlopidine Hydrochloride | Quamed |
| PMS-Ticlopidine | Ticlopidine Hydrochloride | Pharmascience |
| Rhoxal-Ticlopidine | Ticlopidine Hydrochloride | Rhoxalpharma |
| Siclot | Ticlopidine Hydrochloride | Siam Pharmaceutical |
| Strokan FC | Ticlopidine Hydrochloride | CCM Duopharma BioTech |
| Tacron | Ticlopidine Hydrochloride | Korea United; Kyowa Hakko; Ziwell Medical |